Skip to contentB
BIO-TECHNE Corp
B
TECHBIO-TECHNE Corp Q2 2014 · 10-Q
Revenue$84.02M$84.02M+11.9% vs Q2 2013 Net Income$25.06M$25.06M−1.2% vs Q2 2013 EPS Diluted$0.68$0.68−1.4% vs Q2 2013 Gross Profit$58,593,000+6.0% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BIO-TECHNE Corp · CIK 842023 · Engraved from SEC EDGAR
Operating Cash Flowderived$31,322,000+0.1% Free Cash Flowderived$27,675,000+20.0% Margins · derivedGross margin69.7%−3.9 pt vs Q2 2013
Operating margin42.5%−6.6 pt vs Q2 2013
Net margin29.8%−4.0 pt vs Q2 2013
ended Dec 31, 2013 · filed Feb 4, 2014 · 35 d after period end